
Investment by U.S. private equity firm KKR KKR.N to acquire controlling stake in Healthcare Global Enterprises HEAC.NS will bring in more operational, financial efficiency, PL Capital says
Brokerage raises HEAC's PT to 555 rupees from 535 rupees, maintains "buy" rating
Expects KKR to drive growth in the cancer care provider through bed expansion, assets' rationalization, margins expansion
Co's asset-light approach with focus on partnerships has made its model more capital efficient, scalable, PL Capital says
Stock last down 1.5% amid broader market rout